Literature DB >> 24507056

Effect of liver transplantation on glucose levels in patients with prediabetes or type 2 diabetes.

S H Kim1, J M Kim2, K A Lee1, T S Park1, H S Baek1, H C Yu3, H Y Jin4.   

Abstract

BACKGROUND: Liver transplantation (LT) may induce the occurrence of diabetes mellitus. It can be speculated, however, that the LT may have a beneficial effect on glucose metabolism. We therefore conducted a study to examine the changing trends in blood glucose levels before and after LT in patients with prediabetes or type 2 diabetes.
METHODS: In this observational study, we enrolled 47 patients (38 prediabetes and 9 diabetes) who underwent LT. We compared the blood glucose levels between the pre-transplantation (24 months) and the post-transplantation (36 months) periods and analyzed the diverse factors affecting glucose levels.
RESULTS: The glucose regulation worsened and insulin dose increased in patients with diabetes, which was notably seen during the steroid maintenance period. Following steroid withdrawal, however, there was a decrease in the insulin dose in 55.6% of the patients, and 33.3% of the patients converted from insulin to oral agents. Of the patients with prediabetes, 55.3% developed new-onset diabetes after transplantation (NODAT). However, 18.4% achieved a recovery of glucose levels to normal range. Of the 21 NODAT patients, 52.4% achieved a recovery of glucose level to the prediabetes range after steroid withdrawal. There was a significant correlation between the old age and the persistence of NODAT (P < .05).
CONCLUSIONS: LT may have a diverse effect on glycemia, which may lead to changes in glucose control methods. Therefore, glucose metabolism after LT may need to be differentiated by the underlying glucose disturbance status and the time after LT with or without steroid maintenance period.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24507056     DOI: 10.1016/j.transproceed.2013.05.013

Source DB:  PubMed          Journal:  Transplant Proc        ISSN: 0041-1345            Impact factor:   1.066


  3 in total

1.  Preoperative Glycated Haemoglobin Level and Postoperative Morbidity and Mortality in Patients Scheduled for Liver Transplant.

Authors:  Mohd Qurram Parveez; Karthik Ponnappan; Manish Tandon; Ankur Sharma; Priyanka Jain; Akhil Singh; Chandra Kant Pandey; Varuna Vyas
Journal:  Indian J Endocrinol Metab       Date:  2019 Sep-Oct

2.  Integrated analysis of gene modulation profile identifies pathogenic factors and pathways in the liver of diabetic mice.

Authors:  Thai Quoc Tran; Yuan-Man Hsu; Yu-Chuen Huang; Chao-Jung Chen; Wei-De Lin; Ying-Ju Lin; Wen-Ling Liao; Wei-Yong Lin; Jai-Sing Yang; Jinn-Chyuan Sheu; Shih-Yin Chen; Fuu-Jen Tsai
Journal:  J Diabetes Metab Disord       Date:  2019-11-12

3.  The Degree of Hyperglycemia Excursion in Patients of Kidney Transplantation (KT) or Liver Transplantation (LT) Assessed by Continuous Glucose Monitoring (CGM): Pilot Study.

Authors:  Heung Yong Jin; Kyung Ae Lee; Yu Ji Kim; Tae Sun Park; Sik Lee; Sung Kwang Park; Hong Pil Hwang; Jae Do Yang; Sung-Woo Ahn; Hee Chul Yu
Journal:  J Diabetes Res       Date:  2019-11-27       Impact factor: 4.011

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.